226 related articles for article (PubMed ID: 27014575)
21. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
[TBL] [Abstract][Full Text] [Related]
22. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
[No Abstract] [Full Text] [Related]
23. Reliable analysis of phenylalanine and tyrosine in a minimal volume of blood.
Prinsen HC; Holwerda-Loof NE; de Sain-van der Velden MG; Visser G; Verhoeven-Duif NM
Clin Biochem; 2013 Sep; 46(13-14):1272-5. PubMed ID: 23726812
[TBL] [Abstract][Full Text] [Related]
24. A retrospective study on disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria.
Herle M; Brunner-Krainz M; Karall D; Goeschl B; Möslinger D; Zobel J; Plecko B; Scholl-Bürgi S; Spenger J; Wortmann SB; Huemer M
Orphanet J Rare Dis; 2021 Aug; 16(1):367. PubMed ID: 34412683
[TBL] [Abstract][Full Text] [Related]
25. A highly accurate mass spectrometry method for the quantification of phenylalanine and tyrosine on dried blood spots: Combination of liquid chromatography, phenylalanine/tyrosine-free blood calibrators and multi-point/dynamic calibration.
Yazdanpanah M; Yuan L
Clin Biochem; 2022 Mar; 101():35-41. PubMed ID: 34896097
[TBL] [Abstract][Full Text] [Related]
26. PLASMA PHENYLALANINE DETERMINATION BY QUANTITATIVE DENSITOMETRY OF THIN LAYER CHROMATOGRAMS AND BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY IN RELATION WITH MODERN MANAGEMENT OF PHENYLKETONURIA.
Mihali CV; Petrescu CM; Ladaşiu-Ciolacu FC; Mândruţiu I; Bechet D; Nistor T; Ardelean A; Benga G
Acta Endocrinol (Buchar); 2018; 14(4):556-561. PubMed ID: 31149312
[TBL] [Abstract][Full Text] [Related]
27. A retrospective analysis of metabolic control in children with PKU in the COVID-19 era.
Becsei D; Kiss E; Szatmári I; Arató A; Reusz G; Szabó AJ; Bókay J; Zsidegh P
Mol Genet Metab Rep; 2022 Sep; 32():100897. PubMed ID: 35845719
[TBL] [Abstract][Full Text] [Related]
28. An automated enzymatic method on the Roche COBAS MIRA S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria.
Randell EW; Lehotay DC
Clin Biochem; 1996 Apr; 29(2):133-8. PubMed ID: 8601321
[TBL] [Abstract][Full Text] [Related]
29. Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia.
Andrade F; Cano A; Unceta Suarez M; Arza A; Vinuesa A; Ceberio L; López-Oslé N; de Frutos G; López-Oceja R; Aznal E; González-Lamuño D; de Las Heras J
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441968
[TBL] [Abstract][Full Text] [Related]
30. Comparison of liquid chromatography with tandem mass spectrometry and ion-exchange chromatography by post-column ninhydrin derivatization for amino acid monitoring.
Smon A; Cuk V; Brecelj J; Murko S; Groselj U; Zerjav Tansek M; Battelino T; Repic Lampret B
Clin Chim Acta; 2019 Aug; 495():446-450. PubMed ID: 31077651
[TBL] [Abstract][Full Text] [Related]
31. A Case of Suspected Hyperphenylalaninemia at Newborn Screening by Tandem Mass Spectrometry during Total Parenteral Nutrition.
Pieragostino D; Cicalini I; Di Michele S; Fusilli P; Cotugno G; Ferrante R; Bucci I; Dionisi-Vici C; Stuppia L; De Laurenzi V; Rossi C
Metabolites; 2020 Jan; 10(2):. PubMed ID: 31991569
[TBL] [Abstract][Full Text] [Related]
32. PKU and COVID19: How the pandemic changed metabolic control.
Rovelli V; Zuvadelli J; Ercoli V; Montanari C; Paci S; Dionigi AR; Scopari A; Salvatici E; Cefalo G; Banderali G
Mol Genet Metab Rep; 2021 Jun; 27():100759. PubMed ID: 33907667
[TBL] [Abstract][Full Text] [Related]
33. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of volumetric blood collection devices for the measurement of phenylalanine and tyrosine to monitor patients with phenylketonuria.
Carling RS; Emmett EC; Moat SJ
Clin Chim Acta; 2022 Oct; 535():157-166. PubMed ID: 35995273
[TBL] [Abstract][Full Text] [Related]
35. Phenylketonuria (PKU): A problem solved?
Brown CS; Lichter-Konecki U
Mol Genet Metab Rep; 2016 Mar; 6():8-12. PubMed ID: 27014571
[TBL] [Abstract][Full Text] [Related]
36. Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria.
Curtius HC; Endres W; Blau N
Metabolism; 1994 Apr; 43(4):413-6. PubMed ID: 8159095
[TBL] [Abstract][Full Text] [Related]
37. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
[TBL] [Abstract][Full Text] [Related]
38. Plasma cholesterol in adults with phenylketonuria.
Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR
Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302
[TBL] [Abstract][Full Text] [Related]
39. Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria.
Ceglarek U; Müller P; Stach B; Bührdel P; Thiery J; Kiess W
Clin Chem Lab Med; 2002 Jul; 40(7):693-7. PubMed ID: 12241016
[TBL] [Abstract][Full Text] [Related]
40. The use of mass spectrometry to analyze dried blood spots.
Wagner M; Tonoli D; Varesio E; Hopfgartner G
Mass Spectrom Rev; 2016; 35(3):361-438. PubMed ID: 25252132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
